Clinical trial
Safety and Efficacy of 333369 in the Treatment of Partial Epilepsy
NCT00228969 · SK Life Science, Inc., Industry · Completed
Key facts
| NCT number | NCT00228969 |
|---|---|
| Title | Safety and Efficacy of 333369 in the Treatment of Partial Epilepsy |
| Lead sponsor | SK Life Science, Inc., Industry |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Refractory Epilepsy |
| Intervention type | Drug |
| Interventions | RWJ-333369 |
| Start date | Feb 1, 2005 |
| Primary completion | May 1, 2006 |
| Completion | May 1, 2006 |
| First posted | Sep 29, 2005 |
| Last update posted | Aug 2, 2012 |
| Countries | Argentina, Hungary, Netherlands, Poland, Russia, Spain, United Kingdom, United States |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: